Recommended Reading: The National Register Of Antipsychotic Medication In Pregnancy

Go back to Resource Library
By May 25, 2015 No Comments

Authors: Jayashri Kulkarni, Heather Gilbert, Caroline Gurvich, Natasha Marston, Kay McCauley and Anthony de Castella, VIC.

Year: 2008

Event: 2008 TheMHS Conference


Type of resource: Conference Presentations and Papers

ISBN: 9780975765340

Abstract: Introduction: Current data on antipsychotic medication use in pregnancy is limited.

Aim: The National Register of Antipsychotic Medication in Pregnancy (NRAMP) will provide evidence-based clinical guidelines for the safe use of antipsychotic medication during pregnancy and for one year postnatally.

Method: Participation includes women with a history of mental illness, who are taking antipsychotic medication and who are pregnant or have had a baby in the last 12 months. This is an observational, non-interventional, nationwide study, which follows the journey of mother and baby during pregnancy, delivery and for one year postnatally. Information gathered includes demographics, medical, psychiatric, medication and obstetric history, and information on general health and wellbeing for mother and baby.

Results: Results to date will be presented.

Summary: Collection of ongoing data and resulting guidelines have the potential to provide regular, contemporary updates to clinical treating teams for evidence-based management of women in this vulnerable population group.

This resource is only available for subscribers. If you have a subscription, please log in. Otherwise, click here to purchase a subscription.